ASCOR® (Ascorbic Acid Injection, USP), 500mg/mL, 50mL - Individual Vial

NDC: 67157-101-50

Wholesaler Code
AmerisourceBergen 10188073
Cardinal Health 5451851
Henry Schein Coming Soon
McKesson 3799905
McGuff Medical Company 004400

ASCOR® (Ascorbic Acid Injection, USP), 500mg/mL, 50mL - 25 Vials per Tray

NDC: 67157-101-51

Wholesaler Code
AmerisourceBergen 10189486
Cardinal Health 5458948
Henry Schein 1316682
McKesson 2560910
McGuff Medical Company 009999

Specifications

Individual Vial 25/Tray
Brand Name Ascor® Ascor®
NDC 67157-101-50 67157-101-51
Certified Non-Genetically Modification Organism(GMO) Yes Yes
Generic Name Ascorbic Acid Ascorbic Acid
Medical License Required Yes Yes
FDA Country of Origin United States of America United States of America
Customs Country of Origin United States of America United States of America
Form Pharmacy Bulk Package Pharmacy Bulk Package
Preservative No No
Strength 500 mg/mL 500 mg/mL
Size 50 mL 50 mL
Route of Administration IV IV
Class Rx Rx
Therapeutic Class Vitamin C Vitamin C
Derived from genetically engineered plant No No
Source of Vitamin C Proprietary Proprietary
Thimerosal Free Yes Yes
Storage Temperature Store in refrigerator at 2º to 8º C (36º to 46º F) Store in refrigerator at 2º to 8º C (36º to 46º F)
Protect from Freezing Yes Yes
Expiration Date 2 years from date of manufacture 2 years from date of manufacture
Protect from Light Yes Yes
Vial Height 3 in 3 in
Vial Diameter 1.67 in 1.67 in
Vial Stopper Diameter 0.785 in 0.785 in
Weight 0.32 lbs 6.95 lbs
Height 3 in 3 in
Length 1.75 in 8.5 in
Width 1.75 in 8.5 in
Sold As Individual Vial 25 Vials per Tray

Indication & Important Safety Information


ASCOR® is vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administration is not possible, insufficient or contraindicated.

Limitations of Use:
ASCOR® is not indicated for treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy.

Important Safety Information


Contraindications: None.

Administration site reactions include pain and swelling.

ASCOR® should not be rapidly administered. Rapid intravenous administration (>250 mg/minute) of ASCOR® may cause temporary faintness or nausea, lethargy, flushing, dizziness, and headache.

Acute and chronic oxalate nephropathy have occurred with prolonged administration of high doses of ascorbic acid. ASCOR® is not indicated for prolonged administration. The maximum recommended duration is one week.

In patients with glucose-6-phosphate dehydrogenase deficiency severe hemolysis has occurred.

Ascorbic acid may interfere with laboratory tests based on oxidation-reduction reactions, including blood and urine glucose testing, nitrite and bilirubin levels, and leucocyte count testing. If possible, laboratory tests based on oxidation-reduction reactions should be delayed until 24 hours after infusion of ASCOR®.

Please see accompanying Full Prescribing Information for ASCOR®.

I AM
A HEALTH CARE PROFESSIONAL
I AM NOT
A HEALTH CARE PROFESSIONAL

The information contained in this section of the site is intended for U.S. healthcare professionals only.